Por: The Boston Globe Business December 07, 2022
A Cambridge biotech company using to develop therapies for blood cancers said that its experimental treatment for acute myeloid leukemia proved safe in the first recipient, who is currently in remission.The preliminary results, announced Wednesday morning, were a long time coming for the 7-year-old company. The clinical trial of the therapy was delayed due to the COVID-19 pandemic, and the firm faced difficulties finding volunteers willing to... + full article
The New York Times USA Opinion December 09, 2022
The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.“Time is quickly running out for me,” writes a man in his mid-30s whose DNA harbors a genetic mistake certain to destroy... + más
Justice Alito accused of being SCOTUS leaker after new report: Disgrace | Newsweek
Why would Mac Jones get a second opinion on his injury, and how common is that? | The Boston Globe
Time USA Health December 08, 2022
Cardiovascular disease is the leading cause of death in the U.S. and around the world. Though it’s held the top spot for decades, it wasn’t always the king of mortal maladies. Its ascension was propelled by two of medical science’s greatest successes. “Before the 20th... + más
HDL or ‘good’ cholesterol might not make a difference to heart health: study | New York Post
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
The Verge USA Tech November 15, 2022
Descript’s revamped video editing Storyboard feature launches for all usersDescript’s revamped video editing Storyboard feature launches for all users / Descript’s audio transcripts made editing much easier than using traditional timeline-based software. Now, the company... + más
TikTok update adds new tools to let users edit and adjust videos | 9to5Mac
The Boston Globe USA Business November 05, 2022
A man with muscular dystrophy who was first in line to receive an experimental gene editing therapy tailor-made to treat the cause of his rare form of the disease has died.The creation of for Terry Horgan, 27, was helmed by the Boston- and Connecticut-based nonprofit Cure Rare... + más
Death in CRISPR gene therapy study sparks search for answers | ABC News
ABC News USA Tech November 04, 2022
The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him.Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a... + más
Death in CRISPR gene therapy study sparks search for answers | Associated Press
Starting a Revolution Isn’t Enough | The Atlantic
Forbes USA Business October 28, 2022
Financial advisors applaud the Shook family's effort to raise money to help children suffering from ... [+] a rare form of cancer. (Appearing in Photo L-R: Jeremy, R.J. Jamie, Liz and Jacob.)SHOOK Research Top wealth advisors from major U.S. investment firms donated more... + más
Research groups across the US testing vaccines to help prevent, terminate cancer | WPTV
Cancer death rates fall steadily in the US, with more survivors than ever | CNN
The Boston Globe USA Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider
About iurex | Privacy Policy | Disclaimer |